Journal of Pathology Clinical Research

Papers
(The median citation count of Journal of Pathology Clinical Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Issue Information68
Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma43
Assessment of clinical trial protocols for pathology content using the SPIRIT‐Path guidelines highlights areas for improvement31
A novel telomere biology disease‐associated gastritis identified through a whole exome sequencing‐driven approach25
Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements24
Issue Information24
Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes24
Identification and therapeutic evaluation of ALK rearrangements in non‐small‐cell lung cancer24
Leveraging deep learning to discover interpretable cellular spatial biomarkers for prognostic predictions based on hepatocellular carcinoma histology22
Diffuse glioma with FGFR3‐TACC3 fusion in adults is not a homogenous clinicopathological and molecular entity21
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy19
KRAS mutations and endometriosis burden of disease18
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis18
KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway18
The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer18
Somatic whole exome sequencing of colorectal carcinoma in young patients from sub‐Saharan Africa reveals novel insights16
MET fusions and splicing variants in glioma: a landscape integrating clinical, pathological, and survival features16
15
15
Authors' reply: Re: Koga et al. Retrieval‐augmented generation versus document‐grounded generation: a key distinction in large language models14
Authors' reply: Re: Yang et al . The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK 13
Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite‐instable colorectal cancers12
Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer12
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis12
Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study12
11
Validation of fibroblast activation protein and α‐smooth muscle actin as prognostic biomarkers in prostate cancer through AI ‐assisted image analysis11
Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis11
Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma11
Issue Information10
Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation10
Issue Information10
Engineering the future of 3D pathology10
Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression9
Real‐life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization9
A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome9
Issue Information9
9
Cancer‐associated fibroblasts are associated with CD8 + T cell depletion and poor prognosis in colorectal adenocarcinoma: a multi‐omics and machine l9
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study9
Validation of a whole slide image management system for metabolic‐associated steatohepatitis for clinical trials9
Inter‐rater agreement of HER2 ‐low scores between expert breast pathologists and the Visiopharm digital image analysis application ( 8
pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical p8
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer8
Clinicopathologic and molecular landscape of villitis of unknown etiology: insights from a large‐scale case–control study in PR China8
ATM immunohistochemistry as an effective screening method for POLE 8
Prognostic significance of beta‐adrenergic receptor expression in oesophageal adenocarcinoma8
Issue Information7
7
Exosome‐derived ANXA9 functions as an oncogene in breast cancer7
MMR deficiency is frequent in colorectal carcinomas with diffuse SLFN11 immunostaining: clinicopathologic and molecular study of 31 cases identified among 3,300 tumors7
7
Preservation of cell‐free RNA in percutaneous core‐needle biopsy specimens' supernatants from non‐small cell lung cancer improves genomic testing per7
Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole‐slide histopathology7
Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells6
The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells6
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors6
Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric aden6
Entropy and expertise: assessing changes in pathologists' language over time using the UK Liver Pathology External Quality Assessment scheme6
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma6
Closing the loop – the role of pathologists in digital and computational pathology research6
DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell‐rich histological mimics6
Folate receptor alpha ( FRα ) expression in tubo‐ovarian and endometrial tumors: a study of 923 cases6
Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets5
Hyaluronan accumulation is associated with reduced hyaluronidase expression in renal cell carcinoma, with CD44, HAS1, and HYAL2 emerging as prognostic markers5
Assessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes5
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior5
HISTAI : a valuable dataset with a valuable lesson5
Issue Information5
B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma5
Reduced GATA3 expression associates with immuno‐metabolic alterations and aggressive features in breast cancer5
5
Computational pathology in the age of artificial intelligence – embrace not fear4
Post‐operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression4
Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome‐wide mutation analysis4
ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features4
4
Molecular subtype concordance and metastatic patterns in muscle‐invasive bladder cancer4
Explainability and causability in digital pathology4
Low gamma‐butyrobetaine dioxygenase (BBOX1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma: a machine learning approach4
Mesonephric‐type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX24
Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists4
4
Assessing the association between homologous recombination deficiency scores and treatment response in localized and metastatic prostate cancer4
TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis4
Significance of Siglec‐15 expression in colorectal cancer: association with advanced disease stage and fewer tumor‐infiltrating lymphocytes3
3
Deep learning‐based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images3
Issue Information3
Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma3
AI‐based intra‐tumor heterogeneity score of Ki67 expression as a prognostic marker for early‐stage ER+/HER2− breast cancer3
Reducing the risks of nuclear war – the role of health professionals3
A membranous nephropathy variant mimicking minimal change disease3
Histopathology‐based assessment of the tumour microenvironment in gastrointestinal cancers: practical approaches to prognostication and treatment stratification3
3
Subtype‐associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms3
Which descriptor should spread through air spaces (STAS) be incorporated into? T descriptor versus residual tumor classification3
Issue Information3
Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐1193
Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer3
Large multimodal model‐based standardisation of pathology reports with confidence and its prognostic significance3
Development of a decision tree diagram for classifying study designs in tumour pathology research: a multidisciplinary approach3
Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy2
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading2
Dynamic tuft cell expansion during gastric metaplasia and dysplasia2
Issue Information2
2
Translational milestones in urologic pathology: integrating molecular diagnostics across cancer types2
Diagnosing adult and pediatric extrapulmonary tuberculosis by MPT64 antigen detection with immunohistochemistry and immunocytochemistry using reproduced polyclonal antibodies2
A novel NGS‐based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients2
Issue Information2
A quantitative tumor‐wide analysis of morphological heterogeneity of colorectal adenocarcinoma2
Secretory breast carcinoma: morphologic and molecular heterogeneity with indicators of aggressive potential in a cohort of 29 cases2
The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma2
2
CD70 and PD‐L1 (CD274) co‐expression predicts poor clinical outcomes in patients with pleural mesothelioma2
Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization (FISH) scores from immunohistochemistry images via deep learning2
A robust model training strategy using hard negative mining in a weakly labeled dataset for lymphatic invasion in gastric cancer1
The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK / ERK mutat1
Retrieval‐augmented generation versus document‐grounded generation: a key distinction in large language models1
Spatial heterogeneity of antibody–drug conjugate targets in pancreatic ductal adenocarcinoma1
Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma1
Optimization of deep learning models for the prediction of gene mutations using unsupervised clustering1
High chromosomal instability is associated with higher 10‐year risks of recurrence for hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer patients: clinical evi1
Reduced folate receptor alpha ( FOLR1 ) protein expression in fallopian tubes from premenopausal women: implications for the 1
Issue Information1
Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real‐world cohort analysis1
A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal ca1
1
Issue Information1
A deep‐learning workflow to predict upper tract urothelial carcinoma protein‐based subtypes from H&E slides supporting the prioritization of patients for molecular testing1
Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study1
Expression of B7‐H3 and TIM‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with PD‐L1 expression, and prognostic significance1
The expression of YAP1 and other transcription factors contributes to lineage plasticity in combined small cell lung carcinoma1
Pathogenesis of peritoneal high‐grade serous carcinoma after risk‐reducing surgery: a systematic review1
Challenges for pathologists in implementing clinical microbiome diagnostic testing1
Comprehensive transcriptomic profiling reveals molecular characteristics and biomarkers associated with risk stratification in papillary thyroid carcinoma1
Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma1
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classific1
Issue Information1
NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis1
Development of multiple AI pipelines that predict neoadjuvant chemotherapy response of breast cancer using H&E‐stained tissues1
Issue Information1
CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis1
1
Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases1
CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer1
Alcian blue‐positive stromal phenotype in basal cell carcinoma is associated with progression on first‐line hedgehog inhibitors1
0.094385147094727